2021

Articles
Title
YANGZIJIANG: Unwarrantedly undervalued, trading at 0.7x P/Bv and 8x PE
Covid-19: Why wait 2-3 weeks more for infection/ICU trends?
AEM: "It’s time to Add," says CIMB
TRENDLINES: Portfolio company OrthoSpin finds acquirer paying US$79.5 m
REX INT'L: "Medium-sized oil companies with low production costs and overheads will do well"
YANGZIJIANG SHIPBUILDING: "Maintain Add, TP S$1.91," says CIMB
ISOTeam: Novel roach-buster product approved under NEA's stringent criteria
WILMAR: Best 3Q core earnings since listing; target $6.15
Covid-19: What are death risks for various age groups of seniors?
UNI-ASIA GROUP: Buy with target price of $2.34, says UOBKH